Get in Touch



SL-1429

Veliparib, 98%

CAS No. : 
[912444-00-9]    
MDL No. : 
MFCD16661059
Synonyms : (S)-2-(2-Methylpyrrolidin-2-yl)-1H-benzo[d]imidazole-4-carboxamide; ABT-888

Price and Availability
Pack Size Price in USD Quantity Availability Shipping Status
10MG40.00 Back Order Estimated to Ship on 05.09.2024
50MG120.00 Back Order Estimated to Ship on 05.09.2024
100MG150.00 Back Order Estimated to Ship on 05.09.2024
250MG250.00 Back Order Estimated to Ship on 05.09.2024
500MG450.00 Back Order Estimated to Ship on 05.09.2024
Chemical Properties
C13H16N4O 244.29
White solid Not available
For Laboratory research use only, not for drug, household or other uses.
Applications : Veliparib is a potent PARP inhibitor, inhibiting PARP1 and PARP2 with Kis of 5.2 and 2.9 nM, respectively.
References : Donawho CK. et al.: Clin. Cancer Res., 13 (9), 2728-2737, 2007; Penning T. D. et al.: J. Med. Chem., 52(2), 514-523, 2009; Albert J. M. et al.: Clin. Cancer Res., 13(10), 3033-3042, 2007.
Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.
Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.

To receive price and delivery information on larger quantities, please complete the form below and we will respond promptly.

If you login prior to completion of the form, your contact information will automatically populate.

Your request for quote will also be accepted by e-mail at sales@syninnova.com or Fax: +1 780 485 2963.

Product ID : SL-1429

Product Name : Veliparib

Note : If you do not find your required compound in our catalogue, or not commercially available, please contact us, we will assist you to get your desired molecule. We only charge if we deliver to your satisfaction.

Site is under construction and it will coming soon. Please contact us at sales@syninnova.com for COA. Thank you!

Site is under construction and it will coming soon. Please contact us at sales@syninnova.com for HNMR. Thank you!